News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Last call to apply to the ESO Improving Cancer Outcomes and leadership course
ESO/LinkedIn
Jan 14, 2025, 07:37

Last call to apply to the ESO Improving Cancer Outcomes and leadership course

European School of Oncology (ESO) shared a post on LinkedIn:

“Last call to apply to the ESO Improving Cancer Outcomes and leadership course!

This ESO course is designed to equip mid-career cancer healthcare professionals, industry experts, patient advocates, and regulatory personnel with essential skills for strategic planning and implementing strategies.

Take the next step in your career and be part of the change!

Deadline for application: 20 January 2025.”

cancer cancer outcomes eso European School of Oncology healthcare professionals OncoDaily Oncology
Special Coverage
Blog
Jun 19, 2025, 16:57
David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients
Blog
Jun 19, 2025, 16:21
Neeraj Agarwal: Poor Outcomes with SOC in mHSPC Prostate Cancer Patients With HRR Mutation
Blog
Jun 19, 2025, 16:12
World Kidney Cancer Day 2025: Uniting for Progress in the Fight Against Renal Cell Carcinoma
Blog
Jun 19, 2025, 16:01
IARC Marks World Kidney Cancer Day with New Video and Project Highlights
Science
Jun 19, 2025, 15:50
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Opinion
Jun 19, 2025, 15:47
Mostafa Faisal: Primary Refractory AML and Allo-HCT - A 10-Year Retrospective Study from Japan
Blog
Jun 19, 2025, 15:36
Amol Akhade: KEYNOTE-689 - A Turning Point in Resectable HNSCC - Or a Cautious Step Forward?
Drugs
Jun 19, 2025, 15:30
Graham Collins: Nivo-AVD vs BV-AVD in Older Patients (60+) with Hodgkin Lymphoma
Blog
Jun 19, 2025, 15:15
Antonio Jimenez Jimenez Shared Findings from the Multicenter ACCESS trial, Supported by CIBMTR and NMDP
Blog
Jun 19, 2025, 14:35
Peter Pisters: Pleased to Join the 1st Institute for Cell Therapy Discovery and Innovation's External Advisory Board meeting
Insight
Jun 19, 2025, 14:22
Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response
Blog
Jun 19, 2025, 13:42
Raffaele Colombo: Preclinical development of DB-1419 published on Clinical Cancer Research AACR